NUTRA PHARMA CORP. Net Income (Loss) Attributable to Parent, Diluted
NUTRA PHARMA CORP. (NPHC) reported Net Income (Loss) Attributable to Parent, Diluted of -$1.39 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-11-24.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2025-11-24
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for the quarter ending 2023-12-31 was -$243.06K, a 107.36% decline year-over-year.
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for the quarter ending 2023-09-30 was -$278.49K.
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for the quarter ending 2023-06-30 was -$279.25K.
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for the quarter ending 2023-03-31 was -$592.56K, a 116.12% decline year-over-year.
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for fiscal 2023 was -$1.39M, a 118.20% decline from fiscal 2022.
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for fiscal 2022 was $7.65M.
- NUTRA PHARMA CORP. net income (loss) attributable to parent, diluted for fiscal 2021 was -$13.10M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 3 month | Net Income (Loss) Attributable to Parent, Diluted 6 month | Net Income (Loss) Attributable to Parent, Diluted 9 month | Net Income (Loss) Attributable to Parent, Diluted 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$243.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-24 | -$521.55K derived: sum of 2 quarters · filed 2025-11-24 | -$800.80K derived: sum of 3 quarters · filed 2025-11-24 | -$1.39M 10-K · filed 2025-11-24 |
| 2023-09-30 | -$278.49K 10-Q · filed 2025-10-28 | -$557.73K derived: sum of 2 quarters · filed 2025-10-28 | -$1.15M 10-Q · filed 2025-10-28 | $2.15M derived: sum of 4 quarters · filed 2025-11-24 |
| 2023-06-30 | -$279.25K 10-Q · filed 2025-10-23 | -$871.81K 10-Q · filed 2025-10-23 | $2.43M derived: sum of 3 quarters · filed 2025-11-24 | $2.34M derived: sum of 4 quarters · filed 2025-11-24 |
| 2023-03-31 | -$592.56K 10-Q · filed 2025-10-16 | $2.71M derived: sum of 2 quarters · filed 2025-11-24 | $2.62M derived: sum of 3 quarters · filed 2025-11-24 | $1.97M derived: sum of 4 quarters · filed 2025-11-24 |
| 2022-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-24 | $3.21M derived: sum of 2 quarters · filed 2025-11-24 | $2.56M derived: sum of 3 quarters · filed 2025-11-24 | $7.65M 10-K · filed 2025-11-24 |
| 2022-09-30 | -$92.38K 10-Q · filed 2025-10-28 | -$738.17K derived: sum of 2 quarters · filed 2025-10-28 | $4.35M 10-Q · filed 2025-10-28 | $5.11M derived: sum of 4 quarters · filed 2025-10-28 |
| 2022-06-30 | -$645.80K 10-Q · filed 2025-10-23 | $3.79M 10-Q · filed 2025-10-23 | $5.20M derived: sum of 3 quarters · filed 2025-10-23 | $18.13M derived: sum of 4 quarters · filed 2025-10-23 |
| 2022-03-31 | $3.68M 10-Q · filed 2025-10-16 | $5.85M derived: sum of 2 quarters · filed 2025-10-16 | $18.77M derived: sum of 3 quarters · filed 2025-10-16 | $20.55M derived: sum of 4 quarters · filed 2025-10-16 |
| 2021-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-03 | $15.10M derived: sum of 2 quarters · filed 2025-09-03 | $16.87M derived: sum of 3 quarters · filed 2025-09-03 | -$13.10M 10-K · filed 2025-09-03 |
| 2021-09-30 | $12.93M 10-Q · filed 2022-11-21 | $14.70M derived: sum of 2 quarters · filed 2022-11-21 | -$15.26M 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $1.77M 10-Q · filed 2022-08-22 | -$30.70M 10-Q · filed 2022-08-22 | ||
| 2021-03-31 | -$34.02M 10-Q · filed 2022-05-20 | |||
| 2020-09-30 | -$161.83K 10-Q · filed 2021-11-10 | -$1.67M derived: sum of 2 quarters · filed 2021-11-10 | -$1.29M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$1.51M 10-Q · filed 2021-09-24 | -$1.13M 10-Q · filed 2021-09-24 | ||
| 2020-03-31 | -$662.36K 10-Q · filed 2021-09-17 | |||
| 2019-09-30 | -$487.07K 10-Q · filed 2021-08-12 | -$2.16M derived: sum of 2 quarters · filed 2021-08-12 | -$2.56M 10-Q · filed 2021-08-12 | |
| 2019-06-30 | -$1.67M 10-Q · filed 2021-08-05 | -$2.07M 10-Q · filed 2021-08-05 | ||
| 2019-03-31 | -$400.44K 10-Q · filed 2021-07-23 |